Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Stratpharma and Luqa Extend China Dermatological Partnership

publication date: Sep 11, 2013
Stratpharma, a Swiss company focused on dermatology products, extended its relationship with Luqa Pharmaceuticals, which is headquartered in Hong Kong. Luqa is already responsible for China distribution of Stratpharma’s scar management gel, Strataderm. Luqa will now also distribute additional Stratpharma dermatological products in China, and it will have preferential China rights to Stratpharma's new products under development. Luqa will launch four Stratpharma products in the next three years. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital